SUO Awards

Young Investigator Award

Recognition by the Society of excellence in clinical practice and/or basic research that has contributed to improvement of clinical care and progress in science. The recognition may be for a singular contribution or a consistent pattern of performance (and contributions) within 10 years of completion of residency or fellowship which (have) has fulfilled the criteria of advancing the field or holds strong promise of doing so in the immediate future.

Awarded a medal at the AUA meeting.

Young Investigator Award Winners:

David Miller, MD, MPH (Spring 2014)
Surena Matin, MD (Spring 2013)
Andrew J. Stephenson, MD (Spring 2012)
Yair Lotan, MD (Spring 2011)
Brent K. Hollenbeck, MD, MS (Spring 2010)
Daniel W. Lin, MD (Spring 2009)
Jodi Kathleen Maranchie, M.D. (Spring 2008)
Kenneth S. Koeneman, MD  (Spring 2007 tied for award) 
David Ornstein, MD  (Spring 2007 tied for award) 
Adam Kibel, MD (Spring 2006)
Martin G. Sanda, MD (Spring 2005)
Robert E. Reiter, MD (Spring 2004)
John P. Stein, MD (Spring 2003)
Martin Gleave, MD (Spring 2002)

Huggins Medal

Recognition of the Society of a major contribution and/or lifetime achievement in research and/or clinical practice that has contributed to the progress in the treatment for patients with genitourinary neoplasms.

Awarded a medal at the AUA and/or December meeting.

Mark A. Rubin, MD, 2012 Huggins Medal Recipient, pictured with Eric Klein, MD (on left)

Huggins Medal Award Winners:

Ralph deVere White, MD (Winter 2013)
Mark A. Rubin, MD (Winter 2012)
Paul H. Lange, MD (Winter 2011)
Charles L. Sawyers, MD (Winter 2010)
W. Marston Linehan, MD (Winter 2009)
Ian M. Thompson Jr., MD (Winter 2008)
Fritz Schroder, MD, PhD (Winter, 2006)
William Shipley, MD (Winter, 2005)
Donald G. Skinner, MD (Winter, 2004)
Patrick C. Walsh, MD (Winter, 2003)
John T. Grayhack, MD (Winter, 2002)
John P. Donohue, MD (Winter, 2001)

SUO Medal

Awarded to an individual for a specific achievement and/or significant contributions in the field of urologic oncology.

Awarded a medal at the AUA meeting.

SUO Medal Award Winners:

Laurence Klotz, MD (Spring 2014)
Fritz H. Schröder, MD (Spring 2012)
Michael A.S. Jewett, MD (Spring 2011)
Peter Carroll, MD, MPH (Spring 2010)
Urs E. Studer, MD (Spring 2009)
John P. Stein, MD (Spring 2008)
Harry W. Herr, MD (Spring 2007)
James Montie, MD (Spring 2006)
Joseph Smith, MD (Spring 2006)
Richard Dwayne Williams, M.D. (Spring, 2005)
Peter Scardino, M.D. (Spring, 2005)
W. Marston Linehan, M.D. (Spring, 2004)
Paul F. Schellhammer, M.D. (Spring, 2004)
Jerome P. Richie, M.D. (Spring, 2003)
Jean B. deKernion, M.D. (Spring, 2003)
David F. Paulson, M.D. (Spring, 2003)

Whitmore Lecturer

The Willet F. Whitmore Jr. Lectureship was established in 1993 as a keynote address to be delivered at the Annual Meeting and as a tribute to Dr. Whitmore, who embodied the field of urologic oncology as a premier urologic surgeon and as a pioneer in the multidisciplinary aspects of urologic care. Of all the contributions that Dr. Whitmore made to urology, his proudest and most enduring was his role in defining the specialty of urologic oncology. He was the first to establish a Clinical Fellowship in Urologic Oncology and, later, a year of research. His interest and dedication to proper training in urologic oncology led to his election as first president of the Society of Urologic Oncology. Dr. Whitmore was the first Whitmore Lecturer in 1994. Dr. Whitmore died on May 8, 1995, from carcinoma of the prostate, a disease he devoted his life to treating.

Awarded Honorary Members, a $2000 honorarium, and a plaque at the AUA meeting.

Whitmore Lecturers:

Mark Soloway, MD (Spring 2014)
Urs E. Studer, MD (Spring 2013)
Alvaro Morales, MD, FRCSC, FACS (Spring 2012)
Mark Litwin, MD (Spring 2011)
Joel Sheinfeld, MD (Spring 2010)
Harry Herr, MD (Spring 2009)
Patrick Walsh, MD (Spring 2008)
Peter Scardino, MD (Spring 2007)
Andrew C. Novick, MD (2006)
Jean deKernion, M.D. (2005)
Paul H. Lange, M.D. (2004)
Lawrence Einhorn, M.D. (2003)
Andrew C. von Eschenbach, M.D. (2002)
Peter A. Jones, Ph.D., D.S.C. (2001)
John Mendelsohn, M.D., Ph.D., M.A. (2000)
Leroy Hood, M.D., Ph.D. (1999)
William R. Fair, M.D. (1998)
Richard D. Klausner, M.D. (1997)
Mark H. Skolnick, M.D. (1996)
John P. Donohue, M.D. (1995)
Willet F. Whitmore, Jr., M.D. (1994)

Distinguished Service Award

Nominees for the SUO Distinguished Service Award should be an urologist whose actions at work or in the community exceed job expectations and reflect values of compassion, respect, trust, commitment to excellence and teamwork, and also educate the community about prostate cancer.

Dr. Michael Cookson is honored at the SUO Winter Meeting
in Bethesda with a distinguished presidential award
for his work as the OKAT representative

Distinguished Service Award Winners:

Jeffrey Holzbeierlein, MD, FACS (Spring 2014)
Michael S. Cookson, MD (Winter 2011)
Sam S. Chang, MD (Spring 2005)

Prostate Cancer Foundation Award

PCF and its partners grant awards that recognize top presentations at international cancer research meetings. Recognition Awards go to investigators not currently funded by PCF who have a record of outstanding accomplishments in prostate cancer research.

Awarded at the AUA meeting:

Jerome P Richie, MD (Spring 2013)
Stacey A. Kenfield, ScD (Spring 2013)
Glenn Salkeld, MPH, PhD (Spring 2013)
Jennifer Rider, MD (Spring 2012)
Oliver Sartor, MD (Spring 2012)
Joseph Chin, MD (Spring 2012)
Behfar Ehdaie, MD (Spring 2011)
Hiroaki Matsumoto (Spring 2011)
Grant Izmirlian (Spring 2011)
Eric Klein, MD (Spring 2010)
Steven L. Chang, MD (Spring 2010)
Christian Thomas, MD (Spring 2010)

December Meeting Fellow/Resident Poster Award

These awards are selected by the Young Urologic Oncologists Committee at the meeting. The Committee selects the three best posters presented at the meeting by a resident or fellow. The awardees are recognized at the meeting and presented a plaque.

December Meeting 2013 Fellow/Resident Poster Award Winners:

Thursday, December 5th Winners

Christopher Barbieri, PhD, MD (#178) SPOP Mutations In Prostate Cancer Across Ethnically and Geographically Diverse Patient Cohorts (New York-Presbyterian Hospital)

Adam Weiner, BS (#67) Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications For Use of Active Surveillance (2004-2010)

Daniel Yelfimov, MD (#88) Imaging of Prostatic Anatomy in Patient with Known Prostate Cancer Using Magnetic Resonance Elastography: A Feasibility Study

Friday, December 6th Winners

Jeffrey Tomaszewski, MD (#110) Treatment Delay for Muscle Invasive Bladder Cancer: Implications for Regionalization of Care(Fox Chase Cancer Center)

Paul R. Womble, MD (#184) Infection-Related Hospitilzations after Prostate Biopsy in a State-Wide Quality Improvement Collaborative (University of Michigan, Ann Arbor)

Michael A. Liss, MD (#175) Mortality Benefit of Screening Men with a Family History of Prostate Cancer as a Surrogate for High Genetic Risk in the PLCO Trial (UC San Diego)


December Meeting 2012 Fellow/Resident Poster Award Winners:

Thursday, November 29th Winners

Mark Preston, MD (#99) The Association Between Finasteride Use and High-Grade or Lethal Prostate Cancer (Dana Farber Cancer Center)

Joshua Logan, MD (#56) An Inhibitor of Cyclin-Dependent Kinase 4/6, Demonstrates, Differential Inhibition of Proliferation in RCC at Nanomolar Concentrations and Molecular Markers Predict for Sensitivity (UCLA)

Christopher Anderson, MD (#31) Women are Less Likely To Receive Evidence-Based Processes of Care for the Treatment of Bladder cancer as Compared to Men (Vanderbilt University)

Friday, November 30th Winners

Matthew Wszolek, MD (#131) Microrna 200 Family Members Predict Prognosis in Muscle Invasive Urothelial Carcinoma of the Bladder (MD Anderson)

Michael Large, MD (#119) The Impact of Running Versus Interrupted Ureteroenteric Anastomosis on Rate of Ureteral Structure in Radical Cystectomy (University of Chicago)

Lih-Ming Wong (#178) Active Surveillance: Predictors of Pathological Re-Classification on the Second Prostatic Biopsy


December Meeting 2011 Fellow/Resident Poster Award Winners:

Thursday, December 1 st Winners

Todd M. Morgan, MD (#40) Novel Renal Cell Carcinoma Biomarker Identification from Urinary Exosomes (Vanderbilt University)

Karim Chamie, MD (#11) The Impact of Accurate Staging on Bladder Cancer Survival: A Process-Outcomes Link (UCLA)

David Margel, MD (#67) Impact of Prostate MRI on Disease Reclassiciation Among Active Surveillance Candidates—A Prospective Cohort Study

Friday, December 2nd Winners

Robert Chan, MD (#183) Prostate Cancer Immunotherapy Using Bi-Specific Tumor-Reactive T Cells

Christopher Anderson, MD (#166) Trends in Usage of Radical Prostatectomy in the United States: 2000 – 2008


December Meeting 2010 Fellow/Resident Poster Award Winners:

Thursday, December 9th Winners

Alexandra Colquhoun, MD (#45): Utilizing Metformin to Enhance the Efficacy of Androgen Deprivation Therapy in the Treatment of Prostate Cancer (Sunnybrook Health Sciences Centre)

Neema Navai, MD (#61): Genetic Variants in the Vitamin D Pathway Genes Predict Recurrence Risk for Non-muscle Invasive Bladder Cancer (MD Anderson)

Dan Lewinshtein, MD (#99): Risk of Specific Secondary Malignancy in Testicular Cancer Patients Exposed to Radiation (Virginia Mason Medical Center)

Friday, December 10th Winners

David Margel, MD (#104): Stress Proteins and Cytokines May Serve as Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer (Princess Margaret Hospital)

Shaheen R. Alanee, MD (#171): How Does Level I Evidence Affect Treatment Trends of EBRT+AST Combination Therapy for Prostate Cancer? (University of Minnesota)

Kirk A. Keegan II, MD (#191): Financial Implications of Active Surveillance for Prostate Cancer: the Impact of Delayed Active Treatment Versus Initial Treatment (Vanderbilt University)


December Meeting 2009 Fellow/Resident Poster Award Winners:

Thursday, December 3rd Winners

Genevieve Nadeau (#78): Copy number of sex-steroid metabolizing genes as biomarkers of prostate cancer (Laval University)

Melanie Ketchandji (#74): Disseminated prostate cancer CTCs: best marker (UW, Seattle)

William Lowrance (#5): Comparative effectiveness of surgical treatments for PCa (MSKCC) 

Friday, December 4th Winners

Danil Makarov (#109): Inappropriate imaging use for PCa staging (Yale) 

E. Jason Abel (#154): Biopsy of metastatic sites of RCC (MD Anderson)

Sultan Alkhateeb (#192): Prognosis of primary or recurrent T1G3 TCC post BCG (Toronto)


December Meeting 2008 Fellow/Resident Poster Award Winners:

Thursday, December 4th Poster Session I Winners

1st. $350.00
Jay Bakul Shah, MD Anderson Cancer Center
Poster 7 – The SRC inhibitor AZD350 induces growth inhibition and migratory arrest of human bladder cancer cell lines

2nd $250.00
JoseAntonio Karam, University of Texas Southwestern Medical Center
Poster 1 – Uoprregulation of trag3 (taxol resistance associated gene3) is associated with advanced bladder cancer (BCA)

3rd $150.00
Robert Scott Svatek, MD Anderson Cancer Center
Poster 14 – The transcription repressor, ZEB1, regulates epithelial to mesenchmal transition in bladder cancer

Friday, December 5th Poster Session Winners

1st
Vitaly Margulis, MD, MD Anderson Cancer Center
Poster 187 – Multi-institutional validation of the predictive value of KI-67 labeling index patients with urinary bladder cancer

2nd
Vincent Fradet, MD, UCSF, San Francisco
Poster 103 – Dietary Omega-3 Fatty Acids, COX-2 generic variation, and aggressive prostate cancer risk

3rd
Matthew Cooperberg, MD, University of California
Poster 170 – National trends in treatment of stage irenal cell carcinoma


December Meeting 2007 Fellow/Resident Poster Award Winners:

R. Houston Thompson, MD; Memorial Sloan Kettering Cancer Center
B7-H3 AND B7X ARE HIGHLY EXPRESSED IN HUMAN PROSTATE CANCER AND ASSOCIATED WITH DISEASE SPREAD AND POOR OUTCOME
R. Houston Thompson, MD; Xingxing Zang, PhD; Hikmat Al-Ahamadie, MD; Angel Serio, MS; Victor Reuter, MD; James Eastham, MD; Peter Scardino, MD; Padmanee Sharma, MD and James Allison, PhD (Presented by: R. Houston Thompson)

Boris Hadaschick, MD; The Prostate Centre at VGH
INTRAVESICAL THERAPY OF HIGH GRADE BLADDER CANCER WITH HTI-286
Boris Hadaschik, MD; Hans Adomat; Ladan Fazli, MD; Martin Gleave, MD and Alan So, MD (Presented by: Boris Hadaschik)

Shahrokh Shariot, MD; UT Southwestern Medical School
MULTIPLE BIO-MARKERS FOR THE PREDICTION OF BLADDER CANCER RECURRENCE AND MORTALITY
Shahrokh Shariat, MD; Pierre I. Karakiewicz, MD; Raheela Ashfaq, MD; Seth P. Lerner, MD; Ganesh S. Palapattu, MD; Richard J. Cote, MD; Arthur I. Sagalowsky, MD and Yair Lotan, MD (Presented by: Shahrokh Shariat)


December Meeting 2006 Fellow/Resident Poster Award Winners:

Stephen Boorjian, MD; Mayo Clinic
THE IMPACT OF GLEASON SCORE ON THE PREDICTIVE VALUE OF PSA DOUBLING TIME
Stephen Boorjian, MD; Sameer Siddiqui, MD; Brant Inman, MD; Jeffrey Slezak; R. Jeffrey Karnes, MD; Michael Blute, MD and Bradley Leibovich, MD (Presented By: Stephen Boorjian, MD)

Ofer Yossepowitch, MD; Memorial Sloan Kettering Cancer Center
RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED HIGH-RISK PROSTATE CANCER: CRITICAL ANALYSIS OF RISK-ASSESSMENT METHODS
Ofer Yossepowitch, MD; Scott Eggener, MD; Fernando Bianco, MD; Brett Carver, MD; Angel Serio, MD; Peter Scardino, MD and James Eastham, MD (Presented By: Ofer Yossepowitch, MD)

Todd Morgan, MD; University of Washington
DETECTION AND ISOLATION OF DISSEMINATED TUMOR CELLS BY ENRICHMENT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY
Todd Morgan, MD; Daniel Lin, MD; William Ellis, MD; Ian Gallaher, BA; Marty Kinnunen, BA; Bryce Lakely, BA; Paul Lange, MD and Robert Vessella, PhD (Presented By: Todd Morgan, MD)


December Meeting 2005 Fellow/Resident Poster Award Winners:

R. Houston Thompson, MD, Mayo Clinic
COMPLICATIONS FROM CONTEMPORARY OPEN NEPHRON-SPARING SURGERY
R. Houston Thompson, MD, Bradley Leibovich, MD, Christine Lohse, MS, Horst Zincke, MD PhD and Michael Blute, MD (Presented By: R. Houston Thompson, MD)

Bungo Furusato, MD, PhD, Armed Forces Institute for Pathology
GENE EXPRESSION SIGNATURES IN BENIGN AND MALIGNANT EPITHELIAL CELLS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED (FPPE) TISSUES OF PROSTATE CANCER PATIENTS
Bungo Furusato, MD, PhD, Gyorgy Petrovics, PhD, Vasantha Srikantan, DVM, PhD, Syed Shaheduzzaman, PhD, Lakshmi Ravindranath, BS, Martin E Nau, PhD, Maryanne Vahey, PhD, David G McLeod, MD, Shiv Srivastava, PhD and Isabell A Sesterhenn, MD (Presented By: Bungo Furusato, MD, PhD)

Paul Crispen, MD, Fox Chase Cancer Center
TREATMENT WITH TNF-A AND TPEN DECREASES NF-KB ACTIVITY AND INDUCES APOPTOSIS IN PC-3 CELLS
Paul Crispen, MD, Konstantin Golovine, MD PhD, Peter Makhov, MD PhD, Alan Pollack, MD PhD, Eric Horwitz, MD, Richard Greenberg, MD, Robert Uzzo, MD and Vladimir Kolenko, MD PhD (Presented By: Paul Crispen, MD)